ArticleScientific reports2019
EpiRank: Modeling Bidirectional Disease Spread in Asymmetric Commuting Networks.
Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Understanding the role of international flight networks in disease spread: spatial epidemic prevention zones and hierarchical disease control policies.International journal of health geographics · 2026Article
- Simulating targeted vaccination strategies with network-based and agent-based models: A scoping review.PLOS global public health · 2026Article
- Beyond absolute space: modeling disease dispersion and reactive actions from a multi-spatialization perspective.International journal of geographical information science : IJGIS · 2025Article
- Assessing the spatial variability of raising public risk awareness for the intervention performance of COVID-19 voluntary screening: A spatial simulation approach.Applied geography (Sevenoaks, England) · 2022Article
- Evaluating strategies for spatial allocation of vaccines based on risk and centrality.Journal of the Royal Society, Interface · 2022Article
- A Municipality-Based Approach Using Commuting Census Data to Characterize the Vulnerability to Influenza-Like Epidemic: The COVID-19 Application in Italy.Microorganisms · 2020Article
- Networks and long-range mobility in cities: A study of more than one billion taxi trips in New York City.Scientific reports · 2020Article
- Examining the Effect of the Environment and Commuting Flow from/to Epidemic Areas on the Spread of Dengue Fever.International journal of environmental research and public health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Commuting network flows are generally asymmetrical, with commuting behaviors bi-directionally balanced between home and work locations, and with weekday commutes providing many opportunities for the spread of infectious diseases via direct and indirect physical contact. The authors use a Markov chain model and PageRank-like algorithm to construct a novel algorithm called EpiRank to measure infection risk in a spatially confined commuting network on Taiwan island. Data from the country's 2000 census were used to map epidemic risk distribution as a commuting network function. A daytime parameter was used to integrate forward and backward movement in order to analyze daily commuting patterns. EpiRank algorithm results were tested by comparing calculations with actual disease distributions for the 2009 H1N1 influenza outbreak and enterovirus cases between 2000 and 2008. Results suggest that the bidirectional movement model outperformed models that considered forward or backward direction only in terms of capturing spatial epidemic risk distribution. EpiRank also outperformed models based on network indexes such as PageRank and HITS. According to a sensitivity analysis of the daytime parameter, the backward movement effect is more important than the forward movement effect for understanding a commuting network's disease diffusion structure. Our evidence supports the use of EpiRank as an alternative network measure for analyzing disease diffusion in a commuting network.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.